Publikationen von Michael W. Sereda

Meyer zu Hörste, G.; Sereda, M. W.: Genetische Defekte der Myelinbildung: Molekulare Pathogenese der Charcot-Marie-Tooth Neuropathie (CMT1A). Neuroforum 1, S. 25 - 30 (2005)

Grandis, M.; Leandri, M.; Vigo, T.; Cilli, M.; Sereda, M. W.; Gherardi, G.; Benedetti, L.; Mancardi, G.; Abbruzzese, M.; Nave, K.-A. et al.; Nobbio, L.; Schenone, A.: Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. Experimental Neurology 190 (1), S. 213 - 223 (2004)

Michailov, G. V.; Sereda, M. W.; Brinkmann, B. G.; Fischer, T. M.; Haug, B.; Birchmeier, C.; Role, L.; Lai, C.; Schwab, M. H.; Nave, K.-A.: Axonal neuregulin-1 regulates myelin sheath thickness. Science 304 (5671), S. 700 - 703 (2004)

Sereda, M. W.; Meyer zu Hörste, G.; Suter, U.; Uzma, N.; Nave, K.-A.: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine 9 (12), S. 1533 - 1537 (2003)

Schwab, M. H.; Sereda, M. W.; Nave, K.-A.: Neuron-glial interactions: Schwann cells. In: Patterning and cell type specification developing CNS and PNS: Comprehensive developmental neuroscience, Bd. 1, S. 851 - 869 (Hg. Rubenstein, J. L.; Rakic, P.). Elsevier, Amsterdam [et al.] (2013)

Prukop, T.; Stenzel, J.; Wernick, S.; Kungl, T.; Mroczek, M.; Ewers, D.; Nave, K. A.; Sereda, M. W.: Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A), (2019)